Does Inovio Pharmaceuticals Inc (NASDAQ:INO) Have Gas After Even Less Sellers Involved?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Logo

The stock of Inovio Pharmaceuticals Inc (NASDAQ:INO) registered a decrease of 14.71% in short interest. INO’s total short interest was 11.74M shares in September as published by FINRA. Its down 14.71% from 13.76M shares, reported previously. With 1.09M shares average volume, it will take short sellers 11 days to cover their INO’s short positions. The short interest to Inovio Pharmaceuticals Inc’s float is 13.16%.

The stock decreased 1.92% or $0.05 during the last trading session, reaching $2.56. About 218,262 shares traded. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) has declined 32.02% since September 13, 2018 and is downtrending. It has underperformed by 32.02% the S&P500.

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. The company has market cap of $253.51 million. The Company’s SynCon immunotherapy design has the ability to break the immune systemÂ’s tolerance of cancerous cells; and SynCon product design is also intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. It currently has negative earnings. It has completed, current or planned clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, Ebola, Middle East Respiratory Syndrome, and Zika virus.

More notable recent Inovio Pharmaceuticals, Inc. (NASDAQ:INO) news were published by: which released: “Inovio Pharmaceuticals (INO) Reports Q2 Loss, Lags Revenue Estimates – Nasdaq” on August 08, 2019, also with their article: “Why Inovio Pharmaceuticals Stock Is Plunging Today – Nasdaq” published on July 17, 2019, published: “Health Care Sector Update for 02/14/2019: MTFB, MDGS, INO, JNJ, PFE, MRK, ABT, AMGN – Nasdaq” on February 14, 2019. More interesting news about Inovio Pharmaceuticals, Inc. (NASDAQ:INO) were released by: and their article: “If You Had Bought Inovio Pharmaceuticals (NASDAQ:INO) Stock Three Years Ago, You’d Be Sitting On A 58% Loss, Today – Yahoo Finance” published on May 09, 2019 as well as‘s news article titled: “Inovio (INO) Down 36.7% Since Last Earnings Report: Can It Rebound? – Nasdaq” with publication date: June 08, 2019.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.